Marcy Darnovsky

Marcy Darnovsky, PhD, speaks and writes widely on the politics of human biotechnology, focusing on their social justice and public interest implications. Her articles have appeared in The New York Times, Nature, The Guardian, Los Angeles Times, Wall Street Journal, Harvard Law and Policy Review, Democracy, New Scientist and many others. She has appeared on dozens of television, radio, and online news shows and has been interviewed and cited in hundreds of news and magazine articles. She has worked as an organizer and advocate in a range of environmental and progressive political movements, and taught courses at Sonoma State University and at California State University East Bay. Her Ph.D. is from the History of Consciousness program at the University of California, Santa Cruz.

Profile picture for user Marcy Darnovsky

Publications

By Marcy Darnovsky, Ms. Magazine Blog | 06.06.2011

As best as demographers can figure, the world is short about 160 million girls and women–equivalent to the entire female...

By Marcy Darnovsky, Science Progress | 04.22.2011

A new approach to testing the genes of early-stage fetuses could radically alter the experience of pregnancy and parenting. And...

By Francine Coeytaux, Marcy Darnovsky, Susan Berke Fogel, Contraception | 01.01.2011

To view the PDF version of this article, please scroll down to the bottom of this page.

Over the past...

In the News

Ban On Genetically Modified Babies
By Rob Stein, National Public Radio [cites CGS Marcy Darnovsky] | 06.04.2019

A congressional committee voted Tuesday to continue a federal ban on creating genetically modified babies in the United States.

The...

Close-up image of the U.S. Congress
By Marcy Darnovsky, The Hill | 05.29.2019

Last fall, when a Chinese scientist announced that he had created genetically modified twin babies, the world was stunned and...

5 men running on a track
By Nick Busca, Medium [cites CGS' Marcy Darnovsky] | 04.25.2019

Scientists first developed gene therapy techniques in the 1990s, exploring ways to treat disease by modifying malfunctioning cells. In 1997...

Biopolitical Times